Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naïve Mozambican patients

International Journal of STD and AIDS

Volumn 20, Issue 12, 2009, Pages 863-868

  Bhatt, N B ^a   Gudo, E S ^a   Sema C ^a   Bila, D ^a   Di Mattei, P ^b   Augusto, O ^a   Garsia, R ^c,d   Jani, I V ^a  

^a INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

CD4+ T lymphocytes; HIV; HTLV 1; Lymphocytosis; Mozambique

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOZAMBIQUE; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING; SEROLOGY; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTOSIS; MALE; MIDDLE AGED; MOZAMBIQUE; PREVALENCE; VIRAL LOAD;

EID: 74049094763     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008401     Document Type: Article

References (31)

1. Hollsberg P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 1999;63:308-33
2. Gallo RC. Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol Rev 2002;185:236- 65
3. UNAIDS. 2008 Report on the Global AIDS Epidemic, 2008. http://www.unaids.org/en/knowledgecentre/HIVDATA/globalreport/2008/ 2008-global-ASP. ISBN 978 929 2737116
4. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296:679-90
5. Gazzard B, Bernard AJ, Boffito M, et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med 2006;7:487-503
6. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society - USA panel. Top HIV Med 2006;14:827-43
7. Armah HB, Narter-Olaga EG, Adjei AA, Asomaning K, Gyasi RK, Tettey Y. Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana. J Med Microbiol 2006;55(Part 6):765-70
8. Van Rensburg EJ, Lemmer HR, Joubert JJ. Prevalence of viral infections in Mozambican refugees in Swaziland. East Afr Med J 1995;72:588-90
9. Collenberg E, Ouedraogo T, Ganame J, et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J Med Virol 2006;78:683-92
10. Louis JP, Gardon J, Trebucq A, et al. Epidemiological features of retroviral infection by HTLV-1 in central Africa. Bull Soc Pathol Exot 1993;86:163-8
11. Saxinger W, Blattner WA, Levine PH, et al. Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science 1984;225:1473-6
12. Holmgren B, da Silva Z, Larsen O, Vastrup P, Andersson S, Aaby P. Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau. Aids 2003;17:241-53
13. van der Ryst E, Joubert G, Smith MS, Terblanche M, Mollentze F, Pretorius AM. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study. Cent Afr J Med 1996;42:65-8
14. Barcellos NT, Fuchs SC, Mondini LG, Murphy EL. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil. Sex Transm Dis 2006;33:302-6
15. Broutet N, de Queiroz Sousa A, Basilio FP, Sa HL, Simon F, Dabis F. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994. Int J STD AIDS 1996;7:365-9
16. Carneiro-Proietti AB, Ribas JG, Catalan-Soares BC, et al. Infection and disease caused by the human T-cell lymphotropic viruses type I and II in Brazil. Rev Soc Bras Med Trop 2002;35:499-508
17. Gotuzzo E, Escamilla J, Phillips IA, Sanchez J, Wignall FS, Antigoni J. The impact of human T-lymphotrophic virus type I/II infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome. Arch Intern Med 1992;152:1429-32
18. Morimoto HK, Caterino-De-Araujo A, Morimoto AA, et al. Seroprevalence and risk factors for human T-cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Parana, Brazil. AIDS Res Hum Retroviruses 2005;21:256-62
19. Scapellato PG, Bottaro EG, Seoane MB, et al. Clinical, epidemiological and immunological study of patients coinfected with HIV and HTLV-1. Medicina (B Aires) 2004;64:413-8
20. Schechter M, Harrison LH, Halsey NA, et al. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA 1994;271:353-7
21. Fantry L, De Jonge E, Auwaerter PG, Lederman HM. Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. Clin Infect Dis 1995;21:1466-8
22. Schechter M, Moulton LH, Harrison LH. HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:308-11
23. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006;296:827-43
24. Plancoulaine S, Buigues RP, Murphy EL, et al. Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana. Int J Cancer 1998;76:331-6
25. Ampofo W, Nii-Trebi N, Ansah J, et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiol 2002;40:3523-5
26. Analo HI, Akanmu AS, Akinsete I, Njoku OS, Okany CC. Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria. Cent Afr J Med 1998;44:130-4
27. Beilke MA, Theall KP, O'Brien M, et al. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 2004;39:256-63
28. Gouws E, White PJ, Stover J, Brown T. Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect 2006;82(Suppl. 3):iii51-5
29. Hunter DJ. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention. Epidemiology 1993;4:63-72
30. Guerreiro JB, Porto MA, Santos SB, Lacerda L, Ho JL, Carvalho EM. Spontaneous neutrophil activation in HTLV-1 infected patients. Braz J Infect Dis 2005;9:510-4
31. Harrison LH, Schechter M. Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression? AIDS Patient Care STDS 1998;12:619-23